Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Azd5863 – Application in Therapy and Current Clinical Research
Estudio de AZD5863 en Adultos con Tumores Sólidos Avanzados o Metastásicos
Study of AZD5863 for Adults with Advanced or Metastatic Solid Tumors
AZD5863 / Harbour BioMed, AstraZeneca
Study of AZD5863 in Adult Participants with Advanced or Metastatic ...
AZD5863-药品详情-NextPharma®数据库-ByDrug-医药魔方数据库
阿斯利康 CD3/CLDN18.2 双抗国内获批临床,引进自和铂医药_Insight_数据_来自
(PDF) 1169 AZD5863: a specific, potent, affinity-optimized claudin 18.2 ...
(PDF) 1073 AZD5863, a CLDN18.2 and CD3 binding T-cell engager ...
How does AstraZeneca's PARP inhibitor differentiate?
Molecular characterization and cytotoxic effects of AZD5363, AZD8542 ...
阿斯利康 B7-H4 ADC 国内临床即将启动!中国研发提速中_药物_Enhertu_研究
本周创新药获批、NDA和IND,全球创新药NDA、III期临床汇总|获批|汇总|药物|企业|-健康界
Clonogenic analysis of the AZD5363+AZD8542+RV AZD5363+AZD8542+CCR and ...
An affinity-modulated T cell engager targeting Claudin 18.2 shows ...
| AZD5363 and AZD8835 sensitize ovarian cancer cells to cisplatin and ...
mSiO2-Au 纳米载体将 AZD5363 靶向递送至 T 细胞急性淋巴细胞白血病,Colloids and Surfaces B ...
Preclinical Pharmacology of AZD5363, an Inhibitor of AKT ...
Pharmacodynamic study of tumors treated with AZD5363 or in combination ...
AZD5363 inhibits the proliferation of liver cancer cells. (A) The HepG2 ...
AZD8931 synergises with AZD5363 to inhibit cell growth in... | Download ...
Treatment with AZD5363 reduces the proportion of proliferating vascular ...
AZD5363 inhibits prostate cancer tumor growth and induces cell-cycle ...
Frontiers | AZD5363 Inhibits Inflammatory Synergy between Interleukin ...
Claudin18.2:不止眼前的抗体/ADC ,还有远方的CAR-T与mRNA药物-MedSci.cn
Combination of AZD5363 with doxorubicin induces apoptosis in ...
AKT Antagonist AZD5363 Influences Estrogen Receptor Function in ...
아스트라제네카, 차세대 항암제 `AZD5863` 임상서 유망한 결과,아스트라제네카(ADR),AZN | 한국경제TV 와우글로벌
Claudin 18.2: A Promising New Target for Breakthrough Cancer Treatments ...
阿斯利康B7-H4 ADC在国内获批临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Allele-Specific Disruption of a Common STAT3 Autosomal Dominant Allele ...
| Radiosensitivity is associated with a differential antitumour immune ...
德琪医药布局CLDN18.2 ADC:针对CLDN18.2低表达有效,抗体细节在ADC开发中不容忽视_凤凰网
接轨国际,阿斯利康一日两款1类新药国内申请临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Preclinical in vivo characterization of the anti-tumor activity of a ...
AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and ...
Capivasertib (AZD5363) (AZD-5363) | CAS 1143532-39-1 | AbMole ...
恒瑞 PD-1 美国报上市、奥希替尼 3 期临床 FLAURA2 试验成功、华东医药申报三靶降糖药…|Insight 新药周报
Hypertrophic Cardiomyopathy Medical Society (HCMS) on LinkedIn: #hcms2023
AZD5363 could target mitochondrial dynamics in 3D cultured stem cell ...
Preclinical Studies of TAC01-CLDN18.2, an Autologous Claudin 18.2 ...
Chad Burchett on LinkedIn: Roanoke-Blacksburg Technology Council names ...
Development of Human Monoclonal Antibody for Claudin-3 Overexpressing ...
特医食品进入爆发期?浙江企业获投超亿元_纤维_患者_治疗
제일약품 ‘네수파립’, 췌장암 치료 미래 견인 신약으로 ‘주목’ - 헬스코리아뉴스
Study on the Effectiveness and Safety of Subcutaneous Infliximab for ...
和铂医药与阿斯利康深化战略合作,持续赋能生物医药本土创新医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Structure of AZD3582. | Download Scientific Diagram
阿斯利康「CD19/CD3双抗」在华获批临床 - 知乎
Practical Fragments: Fragments in the clinic: AZD5363
CD25 (IL-2 Receptor α) Mouse anti-Human, BUV563, Clone: 2A3, BD Horizon ...
Claudin-6 Monoclonal Antibody for Immunohistochemistry | Immunotherapy
Anti-claudin 5 antibody [EPR7583] - recombinant (ab131259) | Abcam
AZD8931 enhances the antitumour effects of AZD5363 in the HCC1954 ...
和铂医药与阿斯利康三度携手:独家Harbour Mice®技术引领,45亿合作共研多特异性抗体_摩熵医药
阿斯利康发布第三款CLDN18.2靶向抗体疗法
新一代的“再生元”
国内第5款:阿斯利康CD3/CLDN 18.2双抗申报临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
[Inspiring Target] Breakthroughs of targeting Claudin 6 in mAb, bsAb ...
和铂医药与阿斯利康三度携手:独家Harbour Mice®技术引领,45亿合作共研多特异性抗体_摩熵医药(原药融云)
(PDF) AZD5438 a GSK-3a/b and CDK inhibitor is antiapoptotic modulates ...
Antibody specificity against highly conserved membrane protein Claudin ...
#sitc2024 #preclinicalresearch #preclinicalservices | genOway
AZD-CD | AZ Series | Oriental Motor Malaysia
#preclinicalmodels #preclinicalservices #invivo #translationalresearch ...
slide12
(PDF) Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of ...
Anti-Claudin 1 antibody [EPR25359-48] (ab307692) | Abcam
CD86 Antibodies | Antibodies.com
Anti-Claudin 6 antibody [EPR28103-113] (ab314134) | Abcam
Studie zur Wirkung von ALX148 und Pembrolizumab bei Patienten mit ...
阿斯利康引进双抗在中国获批临床丨“美”天新药事|2023-07-23-美迪西生物医药
Claudin 5 Antibody (34-1600)
Inclusion and Exclusion Criteria in Clinical Trials
Grosszelliges Lungenkarzinom Stadium III – Diagnostik | Europäische ...
AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and ...
Claudin 3 Polyclonal Antibody (34-1700)
Criar e implantar um aplicativo Web Python no Azure usando um modelo ...
CD3/CLDN18.2 双抗国内启动临床试验;IBI389 治疗胰腺癌及胃癌最新数据披露_腾讯新闻
Claudin 3/CLDN3 Antibody
AZD5069, under high fat diet conditions, prevents the accumulation of ...
Invitrogen Claudin 3 Polyclonal Antibody 100 μg; Unconjugated ...
Saluting fall sports standouts with Bay City Athlete of the Week for ...
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell ...
Types and Models of Clinical Trials: A Comprehensive Guide
Claudin 5 Antibody (Monoclonal, 4C3C2)
Application-Specific Validation: A Claudin-6 IHC Monoclonal Antibody
Intratumorale Grippeimpfung und Pembrolizumab bei Patienten mit frühem ...
Claudin 1 Antibody (37-4900)
Claudin 5 Antibody
Claudin 3 Polyclonal Antibody, Invitrogen 500 μL; Unconjugated ...
APC Anti-Claudin 1 抗体 [EPRR18871] (ab303066) | Abcam
Anti-Claudin 18.2 antibody [EPR19202] Rabbit monoclonal (ab222512) | Abcam
Anti-Claudin18.2 + Claudin18.1 antibody [EPR19203] (ab222513) | Abcam
Claudin 5 Antibody (35-2500)
Malignant neoplasm of ampulla of Vater – Basic Information – Overview ...
CD133 Mouse Monoclonal Antibody [A8C3] (HA601024) – HUABIO
DNA-PK inhibitor AZD7648 administered in combination with Top2 poisons ...
Anti-Claudin-18 Isoform2-Anti-CD3 IgG Bispecific Antibody Claudin-18 101541
Anti-Claudin-18 Isoform2-Anti-CD3 IgG Bispecific Antibody, Biotin-Labeled
【天风医药杨松团队|首次覆盖】和铂医药-B:稀缺抗体生态浩海扬帆,开启自研合作 BD 三重奏|杨松_新浪财经_新浪网
Claudin18.2 bispecific T cell engager armed oncolytic virus enhances ...
AZD-CD | BỘ ĐIỀU KHIỂN ĐỘNG CƠ DC ORIRENTAL AZ SERIES - A.S.C VN
Cd3 complex (humanized edg) Humanized CD3 epsilon delta gamma Knockin ...
AZD-CM3 | AZ Series | Oriental Motor Asia Pacific